Hemmo Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Hemmo Pharma Llp

Hemmo Pharma Llp, a active limited liability partnership, was established on 17 March 2016 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAF-9673. Registered under ROC Roc Mumbai I. It has total obligation of contribution of ₹1.55 M.

Its leadership includes Rekha Jairam Hemrajani (Designated Partner), Madhu Vikram Utamsingh (Designated Partner), Vikram Utamsingh (Designated Partner). Past directors included Rekha Jairam Hemrajani, Lalita Anil Matta, Jairam Tejumal Hemrajani. Its latest date of accounts and solvency statement 31 March 2025. It is based at Office No. 2608, 26Th Floor, Prestige Tower Wing C, Shakti Mills Lane, Off Dr. E. Moses Road, Mahalaxmi, Mumbai, Maharashtra, 400011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAF-9673

  • Incorporation Date

    17 March 2016

  • Total Obligation of Contribution

    ₹1.55 M

  • ROC Code

    Roc Mumbai I

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.55 M
  • Company Age 10 Year, 1 Day
  • Last Filing with ROC 31 Mar 2025
Company report

Hemmo Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hemmo Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hemmo Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rekha Jairam Hemrajani Designated Partner 03 Jul 2017 Current
Madhu Vikram Utamsingh Designated Partner 17 Mar 2016 Current
Vikram Utamsingh Designated Partner 17 Mar 2016 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 10 Nov 2022 Past
Pramod Abcsdd Designated Partner 10 Jan 2024 Past
Pramod Abcsdd Partner 03 Jul 2017 Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hemmo Pharma Llp.

Enhance accessibility to Hemmo Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Hemmo Pharma Llp revenue growth over time
Hemmo Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hemmo Pharma Llp?

Unlock access to Hemmo Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hemmo Pharma Llp?

Unlock and access historical data on people associated with Hemmo Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemmo Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemmo Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hemmo Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Hemmo Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Hemmo Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    Rekha Jairam Hemrajani was appointed as a Designated Partner was appointed as a Designated Partner on 03 Jul 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.

  • Director Appointment

    Madhu Vikram Utamsingh was appointed as a Designated Partner was appointed as a Designated Partner on 17 Mar 2016 & has been associated with this company since 10 years 1 day . was recorded as a recent event.

  • Director Appointment

    The activity Vikram Utamsingh was appointed as a Designated Partner was appointed as a Designated Partner on 17 Mar 2016 & has been associated with this company since 10 years 1 day . was completed.

  • LLP Incorporation

    Hemmo Pharma Llp was registered on 17 Mar 2016 with Roc Mumbai I & aged 10 years 1 day as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Hemmo Pharma Llp?

The LLPIN of Hemmo Pharma Llp is AAF-9673.

Where is Hemmo Pharma Llp headquartered?

Hemmo Pharma Llp is headquartered at Office No. 2608, 26Th Floor, Prestige Tower Wing C, Shakti Mills Lane, Off Dr. E. Moses Road, Mahalaxmi, Mumbai, Maharashtra, 400011.

When was Hemmo Pharma Llp incorporated?

Hemmo Pharma Llp was incorporated on 17 March 2016.

Who are the current directors of Hemmo Pharma Llp?

The current directors of Hemmo Pharma Llp are

What is the primary industry of Hemmo Pharma Llp?

The primary industry of Hemmo Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available